GENinCode (LSE:GENI) Operating Cash Flow per Share : £-0.03 (TTM As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is GENinCode Operating Cash Flow per Share?

GENinCode's operating cash flow per share for the six months ended in Dec. 2024 was £-0.01. GENinCode's operating cash flow per share for the trailing twelve months (TTM) ended in Dec. 2024 was £-0.03.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -92.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for GENinCode's Operating Cash Flow per Share or its related term are showing as below:

LSE:GENI' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -92.1 Med: -92.1 Max: -92.1
Current: -92.1

During the past 6 years, GENinCode's highest 3-Year average Operating Cash Flow per Share Growth Rate was -92.10% per year. The lowest was -92.10% per year. And the median was -92.10% per year.

LSE:GENI's 3-Year OCF Growth Rate is ranked worse than
100% of 172 companies
in the Medical Diagnostics & Research industry
Industry Median: 3.35 vs LSE:GENI: -92.10

GENinCode Operating Cash Flow per Share Historical Data

The historical data trend for GENinCode's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GENinCode Operating Cash Flow per Share Chart

GENinCode Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Operating Cash Flow per Share

Get a 7-Day Free Trial

-0.01

-0.06

-0.04

-0.08

-0.03

GENinCode Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Operating Cash Flow per Share	Get a 7-Day Free Trial						-0.02	-0.05	-0.03	-0.02	-0.01

Competitive Comparison of GENinCode's Operating Cash Flow per Share

For the Diagnostics & Research subindustry, GENinCode's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

GENinCode's Price-to-Operating-Cash-Flow Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, GENinCode's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where GENinCode's Price-to-Operating-Cash-Flow falls into.

Save Embed

;

Save Embed

;

GENinCode Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

GENinCode's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2024 is calculated as

Operating Cash Flow per Share (A: Dec. 2024 )	=	Cash Flow from Operations (A: Dec. 2024 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2024 )
	=	-5.173	/	175.023
	=	-0.03

GENinCode's Operating Cash Flow per Share for the quarter that ended in Dec. 2024 is calculated as

Operating Cash Flow per Share (Q: Dec. 2024 )	=	Cash Flow from Operations (Q: Dec. 2024 )	/	Shares Outstanding (Diluted Average) (Q: Dec. 2024 )
	=	-1.784	/	177.118
	=	-0.01

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was £-0.03

GENinCode Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of GENinCode's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

GENinCode Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » GENinCode PLC (LSE:GENI) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

9PL:Germany

Address

Oxford Science Park, John Eccles House, Robert Robertson Avenue, Oxford, GBR, OX4 4GP

Website

https://www.genincode.com

GENinCode PLC is engaged in the genetic risk assessment, prediction, and prevention of cardiovascular diseases including coronary artery diseases such as angina and myocardial infarction (heart attack), stroke, heart failure, hypertension, and other vascular heart diseases. The company's current product portfolio comprises Cardio inCode, LiPID inCode, SuDD inCode, and Thrombo inCode. The company has only one reportable segment the sale of kits and the provision of support services. The Geographic Markets of the group are Chile, France, Italy, Sweden, Mexico, Spain, and the United Kingdom.